- Home
- HLIT vs OCS Comparison
HLIT vs OCS Comparison
Compare HLIT & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLIT
- OCS
- Stock Information
- Founded
- HLIT 1988
- OCS 2003
- Country
- HLIT United States
- OCS Switzerland
- Employees
- HLIT N/A
- OCS N/A
- Industry
- HLIT Radio And Television Broadcasting And Communications Equipment
- OCS Biotechnology: Pharmaceutical Preparations
- Sector
- HLIT Technology
- OCS Health Care
- Exchange
- HLIT Nasdaq
- OCS Nasdaq
- Market Cap
- HLIT 1.0B
- OCS 956.4M
- IPO Year
- HLIT 1995
- OCS N/A
- Fundamental
- Price
- HLIT $9.91
- OCS $17.40
- Analyst Decision
- HLIT Buy
- OCS Strong Buy
- Analyst Count
- HLIT 6
- OCS 4
- Target Price
- HLIT $11.50
- OCS $35.75
- AVG Volume (30 Days)
- HLIT 1.0M
- OCS 13.6K
- Earning Date
- HLIT 10-27-2025
- OCS 11-06-2025
- Dividend Yield
- HLIT N/A
- OCS N/A
- EPS Growth
- HLIT 16.91
- OCS N/A
- EPS
- HLIT 0.58
- OCS N/A
- Revenue
- HLIT $689,084,000.00
- OCS $960,668.00
- Revenue This Year
- HLIT N/A
- OCS $11.49
- Revenue Next Year
- HLIT $25.21
- OCS $1,784.02
- P/E Ratio
- HLIT $17.17
- OCS N/A
- Revenue Growth
- HLIT 24.14
- OCS N/A
- 52 Week Low
- HLIT $7.80
- OCS $11.78
- 52 Week High
- HLIT $15.46
- OCS $23.08
- Technical
- Relative Strength Index (RSI)
- HLIT 60.04
- OCS 50.18
- Support Level
- HLIT $9.78
- OCS $16.00
- Resistance Level
- HLIT $10.19
- OCS $17.34
- Average True Range (ATR)
- HLIT 0.26
- OCS 0.41
- MACD
- HLIT 0.04
- OCS 0.08
- Stochastic Oscillator
- HLIT 73.58
- OCS 66.67
About HLIT Harmonic Inc.
Harmonic Inc engaged in broadband access solutions that enable broadband operators to more efficiently and effectively deploy high-speed internet for data, voice, and video services for their customers and versatile and high-performance video delivery software, products, system solutions and services that enable its customers to efficiently create, prepare, store, playout and deliver a full range of high-quality broadcast and streaming video services to consumer devices, including televisions, personal computers, laptops, tablets, and smartphones. It has two segments, Broadband which provides broadband access solutions and related services, and Others; and Video business provides video processing and production and playout solutions and services, and Others.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.